Avondale Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-260	Closed	-$33.4K	–	129
2024 Q1	$33.4K	Hold	260	–	–	0.02%	95
2023 Q4	$26.9K	Hold	260	–	–	0.02%	97
2023 Q3	$23.6K	Buy	+260	New	+$23.6K	0.02%	101